CGD's work on global health aims to improve the effectiveness of policies and actions of donors (bilateral aid agencies, philanthropic foundations, and multilateral organizations) and to enhance the coordination between these public agents and the private sector. CGD selects challenging and timely topics that demand the attention of global decision-makers faced with complex epidemiological, institutional, and economic choices. Health systems and financing, HIV/AIDS, health product innovation, chronic disease burden, and access to prevention, treatment and care services are among the topics that we address. In many cases, we work with academic, policy, and implementation experts convened in our CGD Working Groups to produce practical solutions that are innovative, viable, and technically sound.
Our work has contributed to significant improvements in policy. Millions Saved: Proven Successes in Global Health, now in its second edition, identifies large-scale, sustained health interventions and the common elements of their success; it has become required reading in global health classes in the United States and internationally. Our work on an Advanced Market Commitment (AMC) for vaccines sparked a $1.5 billion pilot program for to an improved vaccine to prevent pneumococcal disease, which annually kills about 1 million children in poor countries. The report of our Evaluation Gap Working Group led to the creation of the International Initiative on Impact Evaluation (3IE), a new independent body that is working to address the chronic lack of sound empirical studies about how well social development programs work across a range of settings.
For more information on the Center for Global Development’s Global Health work:
CGD's work on global health aims to improve the effectiveness of policies and actions of donors (bilateral aid agencies, philanthropic foundations, and multilateral organizations) and to enhance the coordination between these public agents and the private sector. CGD selects challenging and timely topics that demand the attention of global decision-makers faced with complex epidemiological, institutional, and economic choices. Health systems and financing, HIV/AIDS, health product innovation, chronic disease burden, and access to prevention, treatment and care services are among the topics that we address. In many cases, we work with academic, policy, and implementation experts convened in our CGD Working Groups to produce practical solutions that are innovative, viable, and technically sound.
Our work has contributed to significant improvements in policy. Millions Saved: Proven Successes in Global Health, now in its second edition, identifies large-scale, sustained health interventions and the common elements of their success; it has become required reading in global health classes in the United States and internationally. Our work on an Advanced Market Commitment (AMC) for vaccines sparked a $1.5 billion pilot program for to an improved vaccine to prevent pneumococcal disease, which annually kills about 1 million children in poor countries. The report of our Evaluation Gap Working Group led to the creation of the International Initiative on Impact Evaluation (3IE), a new independent body that is working to address the chronic lack of sound empirical studies about how well social development programs work across a range of settings.
For more information on the Center for Global Development’s Global Health work:
The authors apply Birdsall and Kharas’s Quality of Official Development Assistance (QuODA) methodology to rank donors across 23 indicators of aid effectiveness in health.
As the Global Health Initiative moves into its third year of implementation, Nandini Oomman and Rachel Silverman summarize the current status of this major development initiative, highlight the challenges for the GHI, and propose specific recommendations for a way forward.
This report of the Rethinking U.S. Foreign Assistance Program summarizes the rationale for continued U.S. investment in global health, looks into the evolution of the Global Health Initiative, and recommends a re-boot for the whole enterprise.
After a decade of rapid economic growth, many developing countries have attained middle-income status, but poverty reduction in these countries has not kept pace with economic growth. Most of the world’s poor—up to a billion people—now live in these new middle-income countries. These...
This brief summarizes the recommendations in Achieving an AIDS Transition to use focused policies and well-designed incentives to finally bring the AIDS epidemic under control.
This report of the Working Group on Clinical Trials and Regulatory Pathways provides practical policy recommendations to help provide better, safer, and cheaper medicine and treatment to the 1 billion people suffering from neglected diseases.
This brief outlines the recommendations from the report of the Center for Global Development’s Working Group on Clinical Trials and Regulatory Pathways
After a decade of rapid growth in average incomes, many countries have attained middle-income country (MIC) status, while poverty hasn’t fallen as much as one might expect. As a result, there are up to a billion poor people or a ‘new bottom billion’ living not in the world’s poorest...
After a decade of rapid economic growth, many developing countries have attained middle-income status, but poverty reduction in these countries has not kept pace with economic growth. Most of the world’s poor—up to a billion people—now live in these new middle-income countries. These...
After a decade of rapid growth in average incomes, many countries have attained middle-income country (MIC) status, while poverty hasn’t fallen as much as one might expect. As a result, there are up to a billion poor people or a ‘new bottom billion’ living not in the world’s poorest...
As the Global Health Initiative moves into its third year of implementation, Nandini Oomman and Rachel Silverman summarize the current status of this major development initiative, highlight the challenges for the GHI, and propose specific recommendations for a way forward.
In a pathbreaking follow-up to the 2008 report Girls Count, Miriam Temin and CGD vice president Ruth Levine shed light on the reality of girls’ health worldwide and its enormous on the wellbeing and productivity of girls, their families, and their nations. Start with a Girl: A New Agenda for...
This brief summarizes the recommendations in Achieving an AIDS Transition to use focused policies and well-designed incentives to finally bring the AIDS epidemic under control.
This report of the Rethinking U.S. Foreign Assistance Program summarizes the rationale for continued U.S. investment in global health, looks into the evolution of the Global Health Initiative, and recommends a re-boot for the whole enterprise.
This report of the Working Group on Clinical Trials and Regulatory Pathways provides practical policy recommendations to help provide better, safer, and cheaper medicine and treatment to the 1 billion people suffering from neglected diseases.
Donor spending on global health has surged, yet for many poor people in developing countries even basic prevention and treatment remain elusive. CGD’s newest book, Performance Incentives for Global Health: Potential and Pitfalls, shows how modest payments in cash or kind can get more health from...
The authors apply Birdsall and Kharas’s Quality of Official Development Assistance (QuODA) methodology to rank donors across 23 indicators of aid effectiveness in health.
Once rich-world woes, non-communicable diseases such as diabetes and cancer account for half the burden of disease in the developing world. Yet Rachel Nugent finds that barely 3 percent of aid and philanthropic spending on health addresses this neglected health crisis.
Thomas J. Bollyky was a research fellow at the Center for Global Development, where his research focused on legal and regulatory issues in global health, technological innovation and delivery, and international trade.
Michael Clemens leads CGD's Migration and Development initiative. His research focuses on the effects of international migration on people from and in developing countries. He also serves as CGD’s research manager, directing the Center’s engagement with the academic research community.
Rena Eichler, Center for Global Development Visiting Fellow, concentrates on the application of incentives to improve health system performance. She is an economist with more than fifteen years of experience working on health financing and health systems strengthening in Africa, Latin America...
Amanda Glassman, Director of Global Health Policy and Research Fellow
Amanda Glassman has 20 years of experience working on health and social protection policy and programs in Latin America and elsewhere in the developing world. Before joining CGD, Glassman was principal technical lead for health at the Inter-American Development Bank.
April Harding is a visiting fellow at the Center for Global Development. She is an economist and health systems specialist who joined CGD from the Human Development department in the Latin America and Caribbean region of the World Bank. For the past 8 years she's been leading the Bank's work...
Ruth Levine, Former Vice President for Programs and Operations, and Senior Fellow
Ruth Levine is an internationally recognized expert on global health and health policy. She is a health economist with more than 15 years of experience designing and assessing the effects of social sector programs in Latin America, Eastern Africa, the Middle East, and South Asia. In addition to...
Rachel Nugent, Former Deputy Director of Global Health
Rachel Nugent was the deputy director of global health at the Center for Global Development. She lead CGD’s Demographics and Development in the 21st Century Initiative, managed the Drug Resistance & Global Health Initiative, and conducted research on non-communicable diseases in developing...
Nandini Oomman, Former Director, HIV/AIDS Monitor, and Senior Program Associate
Nandini Oomman was director of the HIV/AIDS Monitor at the Center for Global Development from March 2006 until December 2011. As director, Oomman led three research teams in Uganda, Mozambique, and Zambia to track the effectiveness of the three main aid responses to the epidemic: the Global Fund,...
Mead Over applies economics and statistics in the search for more effective, efficient, and pro-poor health policies in developing countries. His newest book is Achieving an AIDS Transition: Preventing Infections to Sustain Treatment.
Bill Savedoff has been working for more than 20 years on economic and social development issues. His work is focused on finding ways to improve the quality of social services in developing countries, with particular attention to incentives, institutions, and political economy. His most recent book...
Dr. Jeremy Shiffman is Associate Professor of Public Administration and Policy at American University and non-resident fellow at the Center for Global Development.
The authors apply Birdsall and Kharas’s Quality of Official Development Assistance (QuODA) methodology to rank donors across 23 indicators of aid effectiveness in health.
As the Global Health Initiative moves into its third year of implementation, Nandini Oomman and Rachel Silverman summarize the current status of this major development initiative, highlight the challenges for the GHI, and propose specific recommendations for a way forward.
This report of the Rethinking U.S. Foreign Assistance Program summarizes the rationale for continued U.S. investment in global health, looks into the evolution of the Global Health Initiative, and recommends a re-boot for the whole enterprise.
After a decade of rapid economic growth, many developing countries have attained middle-income status, but poverty reduction in these countries has not kept pace with economic growth. Most of the world’s poor—up to a billion people—now live in these new middle-income countries. These...
This brief summarizes the recommendations in Achieving an AIDS Transition to use focused policies and well-designed incentives to finally bring the AIDS epidemic under control.
This report of the Working Group on Clinical Trials and Regulatory Pathways provides practical policy recommendations to help provide better, safer, and cheaper medicine and treatment to the 1 billion people suffering from neglected diseases.
This brief outlines the recommendations from the report of the Center for Global Development’s Working Group on Clinical Trials and Regulatory Pathways
After a decade of rapid growth in average incomes, many countries have attained middle-income country (MIC) status, while poverty hasn’t fallen as much as one might expect. As a result, there are up to a billion poor people or a ‘new bottom billion’ living not in the world’s poorest...
Noncommunicable diseases (NCDs) such as cancer, diabetes, respiratory and cardiovascular diseases, and mental illnesses are the leading cause of death and disability worldwide. The good news is that much of the NCD burden can be prevented through interventions that are affordable in most countries....
This paper briefly assesses the Health Systems Funding Platform and finds that its progress differs little from prior initiatives, although it does present an opportunity to make global health aid more effective.
As GAVI and its new leadership look beyond June 13, Amanda Glassman of CGD and Lisa Carty, Margaret Reeves and Stephen Morrison of CSIS have joined to recommend an agenda that builds on GAVI’s comparative advantage and maximizes impact on child health.
In this paper, background to Kenny’s book Getting Better, the authors investigate the cross-country determinants of health improvements and describe the implications for development policy.
The time is right to reinvigorate UNFPA. Seventeen years after the groundbreaking ICPD meeting, UNFPA needs to make itself the lead agency for population, sexual and reproductive health, and reproductive rights in the UN system, as well as be more visible externally.
In his latest essay, Charles Kenny seeks to revive Solow's model of exogenous growth; growth driven by the global diffusion of new technologies and ideas. He suggests that when it comes to quality of life improvements, institutions may be less important than exogenous factors, like new vaccines,...
Charles Kenny attempts to dispel development pessimists' fears in this essay summarizing his latest book Getting Better: Why Global Development Is Succeeding - And How We can Improve the World Even More (Basic Books). According to Charles, better health, education, greater access to civil and...
Using panel data from Mozambique collected in 2007 and 2008, the authors explore the impact of the food crisis on the welfare of households living with HIV/AIDS. While HIV households have not suffered more from the crisis than others, infected people who experienced a negative income shock also...
Once rich-world woes, non-communicable diseases such as diabetes and cancer account for half the burden of disease in the developing world. Yet Rachel Nugent finds that barely 3 percent of aid and philanthropic spending on health addresses this neglected health crisis.
For the past decade, global AIDS donors have responded to HIV/AIDS in sub-Saharan Africa as an emergency and have mobilized health workers from weak and understaffed workforces. They must begin to address the long-term problems underlying the shortages and the effects of their efforts on the...
This report focuses on the workforce strengthening strategies of three of the major HIV/AIDS donors—the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), and the World Bank’s Africa Multi-country HIV/AIDS...
Improving adolescent girls’ health and wellbeing is critical to achieving virtually all international development goals. Start with a Girl: A New Agenda for Global Health shows why doing so is a global must and identifies eight priorities for international action.
There has been tremendous progress over the last decade in the development of health products for neglected diseases, but two substantial bottlenecks threaten our capacity to bring these products to those in need.
Visiting Fellow Tom Bollyky testified before the U.S. Senate Appropriations Subcommittee on Agriculture, Rural Development, the Food and Drug Administration, and Related Agencies on how the FDA can help develop programs for neglected diseases. Programs for neglected diseases, such as tuberculosis,...
The Center for Global Development’s Drug Resistance Working Group urges pharmaceutical companies, governments, donors, global health institutions, health providers, and patients to collectively and immediately tackle this global health threat by implementing four key recommendations.
In an increasingly interconnected world, drug resistance does not stop at a patient’s bedside—it threatens global health. The conclusions of the Center for Global Development’s Drug Resistance Working Group make clear the need for urgent action to address this growing crisis.
In the final installation of a three-part series, Mead Over estimates the fiscal burden of international AIDS treatment programs, and suggests ways that donors, governments, and patients can sustain current treatments while preventing future cases.
This essay proposes ways to improve the effectiveness of HIV prevention by strengthening incentives for both measurement and achievement. It builds upon a companion essay that proposes an “AIDS Transition”—that is, a gradual reduction in the number of people infected with HIV even as those...
Recognizing the donors’ obligation to sustain financing for the millions of AIDS patient who would not be alive today without it, this essay proposes a dynamic paradigm for the struggle with the AIDS epidemic—“the AIDS transition” —and argues that to most rapidly achieve an AIDS...
Billions of dollars have been allocated to fight HIV/AIDS in poor countries over the past decade, yet less than half of those requiring treatment receive it, and for every two people put on treatment, five more become infected. Donors have to do more with available funds. Now is the time to link...
This report examines the use of performance-based funding (PBF) among the big three funders of HIV/AIDS programs in developing countries: the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the Global Fund to Fight AIDS Tuberculosis and Malaria, and the World Bank’s Multi-Country...
The Private Sector Advisory Facility Working Group recommends a practical way for donors and technical agencies to support successful public-private interactions to strenghthen health systems in developing countries.
In a pathbreaking follow-up to the 2008 report Girls Count, Miriam Temin and CGD vice president Ruth Levine shed light on the reality of girls’ health worldwide and its enormous on the wellbeing and productivity of girls, their families, and their nations. Start with a Girl: A New Agenda for...
In this working paper, commissioned as part of CGD's Drug Resistance Working Group, Prashant Yadav analyzes how changes in supply-chain business practices could help fix the misaligned incentives that hinder worldwide access to high-quality medical goods.
Before a 2006 UN Special Session proclaimed there should be universal access to antiretrovirals (ARV), the life-saving drugs were far too expensive for most people with AIDS. In a new CGD working paper, Ethan Kapstein and Josh Busby examine how activists transformed ARVs from expensive private...
Few people doubt that gender inequality influences the spread of HIV/AIDS, yet public health efforts tend to focus on changing individual behavior rather than addressing structural factors—social, economic, physical and political—that influence the spread and effects of HIV and AIDS. ...
Undernutrition kills more than three million mothers and children annually, and millions more children suffer irreversible, long-term damage to their bodies and minds. Yet nutrition is too often a low priority for rich-world donors and even for governments in the most affected countries. A new CGD...
Gender inequality drives the HIV epidemic, increasing the burden on women and girls and undermining the global response to the disease. A new HIV/AIDS Monitor report finds that despite well-meaning language and admirable broad goals, three of the biggest HIV/AIDS funders have yet to translate...
Donor spending on global health has surged, yet for many poor people in developing countries even basic prevention and treatment remain elusive. CGD’s newest book, Performance Incentives for Global Health: Potential and Pitfalls, shows how modest payments in cash or kind can get more health from...
This dataset compiles selected global variables on AIDS and its treatment and prevention. The data are in the format developed by the Stata statistical software corporation and are intended for use with Over and McCarthy's AIDSCost package for the purpose of projecting the future budgetary cost of...
CGD senior fellow Mead Over and Owen McCarthy offer a users' manual and Stata software to help students and instructors of public health, development economics, or health economics to project the future budgetary cost of AIDS treatment in poor countries and to explore the many factors affecting the...
CGD policy analyst Lindsay Morgan summarizes the global health agendas various organizations have recommended to the Obama administration. She finds that the calls for a smarter, more harmonized, results-based global health agenda are clear.
Rena Eichler and Ruth Levine summarize the findings of their book, Performance Incentives for Global Health: Potential and Pitfalls. Through numerous case studies, they show that carefully designed and implemented performance-based incentive programs can improve developing country health care in...
This report by the UNAIDS Leadership Transition Working Group argues that the new executive director of the Joint United Nations Programme on HIV/AIDS should focus on a few essential tasks: promoting evidence-based prevention and treatment strategies, ensuring that UN agencies adequately support...
Senior fellow Mead Over estimates the effect of AIDS on poverty in South Asia and analyzes public policy options to help the region’s predominantly private health care systems meet the challenge of treating AIDS. He finds that South Asian governments should play a larger role in AIDS treatment...
Throughout Latin America, mothers no longer worry about their children contracting polio; vast regions of Africa are now habitable because river blindness is under control; China has made major inroads against tuberculosis; in Sri Lanka, women can give birth without fear of dying—in sharp...
The debate on user fees in health and education has been contentious, but until recently much of the evidence has been anecdotal. Does charging poor people for health and education services improve or impede access? CGD non-resident fellow Michael Kremer and co-author Alaka Holla survey the...
Nandini Oomman, director of CGD's HIV/AIDS Monitor, calls on President-elect Obama to push PEPFAR (the President's Emergency Plan for AIDS Relief)to release official data on obligations to prime partners, subpartners, and program areas to improve transparency and accountability.
The United States can play an important role in
promoting global development while simultaneously advancing
American interests and prosperity. Intellectual property (IP) rights, such as patents and
copyrights, provide protection against unauthorized copying and
are therefore fundamental to...
U.S. spending on global AIDS is widely seen as a significant foreign policy and humanitarian success, but this success contains the seeds of a future crisis. Treatment costs are set to escalate dramatically and new HIV infections continue to outpace the number of people receiving treatment. Three...
Donors spend billions of dollars to fight HIV/AIDS in developing countries, but poor integration between donors and host country health systems risks undermining international efforts to prevent and treat AIDS. In this analysis, CGD’s HIV/AIDS Monitor argues that donors need to pay more...
U.S. global AIDS spending is helping to prolong the lives of more than a million people, yet this success contains the seeds of a future crisis. Escalating treatment costs coupled with neglected prevention measures mean that AIDS spending is growing so rapidly that it threatens to squeeze out U.S....
The President's Emergency Plan for AIDS Relief (PEPFAR) is the single largest funder of global AIDS relief programs, but it does not regularly release data on how its money is spent. In this report, CGD's HIV/AIDS Monitor Team analyzes a newly available dataset of PEPFAR funding. They find, among...
The President's Emergency Plan for AIDS Relief (PEPFAR) provides more than $5 billion per year to prevent and treat HIV/AIDS. Exactly how is that money spent? Donors, recipients, and even PEPFAR staff are often left guessing, because much of the extensive data the U.S. government collects on the...
This week, public health advocates gather in London to mark the 20th anniversary of the global safe motherhood initiative, launched in 1987 to reduce the number of mothers who die or suffer injury giving birth. Despite the advocates' work, the initiative has yet to gain the political traction...
Donor funding for HIV/AIDS has skyrocketed in the last decade: from US$ 300 million in 1996 to US$ 8.9 billion in 2006. Yet, surprisingly little is known about how this money is spent. Following the Funding for HIV/AIDS, by CGD's HIV/AIDS Monitor team, analyzes the policies and practices of the...
In 2004 a working group of experts was convened by the Center for Global Development to identify cases in which large-scale efforts to improve health in developing countries have succeeded—saving millions of lives and preserving the livelihoods and social fabric of entire communities. Seventeen...
This report of the CGD working group on IMF Programs and Health Spending explores the controversy that surrounds IMF-supported programs in low-income countries and their effect on the health sector. Critics contend that programs unduly constrain health spending though macroeconomic, especially...
This brief summarizes the findings of the CGD working group on IMF Programs and Health Spending, convened in fall 2006 to investigate the effect of International Monetary Fund (IMF) programs on health spending in low-income countries. The report offers clear, practical recommendations for...
Why do some serious health issues--such as HIV/AIDS--get considerable attention and others--such as malaria and collapsing health systems--very little? In this CGD brief, visiting fellow Jeremy Shiffman discusses nine factors that influenced the degree to which national leaders in five countries...
This report of CGD's Global Health Forecasting Working Group, which was convened in early 2006 by senior fellow and director of programs Ruth Levine to sort out why demand forecasting has been so problematic, provides an elegant analysis of the problem and a sensible agenda for action. Their report...
Millions Saved: Proven Success in Global Health is about part of that success story: 17 cases in which large-scale efforts to improve health in developing countries have succeeded - saving millions of lives and preserving the livelihoods and social fabric of entire communities.
The initiative seeks practical ways to prevent or contain the emergence of drug resistance in such high-burden diseases as HIV/AIDS, tuberculosis, and malaria through improvements in common-property management, information flows, and stepped up research and development.
Shortcomings in demand forecasting for essential drugs, vaccines, and diagnostics have led to unnecessarily high prices, supply shortages, and reluctance to invest in R&D for developing-country diseases. To address this challenge, CGD’s Global Health Forecasting Working Group issued...
The agenda describes why and how to provide adolescent girls in developing countries a full and equal chance in life. It offers targeted recommendations for national and local governments, donor agencies, civil society, and the private sector.
The Global Health Policy Research Network served as an umbrella for a large number of CGD initiatives that undertook original, focused research on high-priority global health policy issues.
The Monitor tracked and analyzed the practices of the three major global HIV/AIDS aid initiatives: the Global Fund to Fight AIDS, Tuberculosis and Malaria; the U.S. President's Emergency Plan for AIDS Relief (PEPFAR); and the World Bank's Multi-Country HIV/AIDS Program (MAP).
The Working Group on IMF-Supported Programs and Health Expenditures investigated how macroeconomic policies under IMF programs in low-income countries interacted with the management of health spending in a context of scaled-up aid. Utilizing case studies and cross-country comparisons, the working...
A CGD Working Group produced an economic and legal framework for funds to incentivize vaccine development. The G-7 Finance Ministers endorsed the approach and five donors (Canada, Italy, Norway, UK and Russia, and the Gates Foundation) committed $1.5 billion to create an incentive for a vaccine...
From eradication of polio in Latin America to HIV prevention in Thailand, the 17 cases in this study show that large-scale success in health are indeed possible. A companion website offers a video, teacher's guide, and information about how to achieve future successes.
As the founding executive director of UNAIDS prepared to step down at the end of 2008, CGD and the Economic Governance Programme of Oxford University convened an expert working group to develop recommendations for the incoming leadership of UNAIDS, the Programme Coordinating Board, and other...
Most people understand the personal risks associated with smoking, but surprisingly few understand its impact globally. Every year, more people die form tobacco related illnesses than from HIV/Aids, TB and malaria combined. Nevertheless, governments and international aid agencies have yet ot pay...
The Center for Global Development is proud to have hosted Prof. Michael Kremer (Harvard) and Sarah Baird (GWU) as part of the Massachusetts Avenue Development Seminar (MADS) series. They presented the long-term, follow-up results of Prof. Kremer's research on deworming in Kenyan schools that...
In a recent speech, USAID Administrator Rajiv Shah said “The evidence is clear: vaccines are the best public health investment we can make.” As the Global Alliance for Vaccines and Immunization (GAVI) prepares for its June 2011 pledging conference, CGD hosted a panel to look back at global...
Ten years after President Clinton's initiative to avert a global epidemic of tobacco-related disease, smoking is down in the United States but rising fast in poor countries, where Washington turns a blind eye to aggressive cigarette marketing banned at home.
My guest on this show is Thomas...
To mark the start of the new year, my guest is Amanda Glassman, CGD’s new director of global health. I asked Amanda, who previously worked at the Inter-American Development Bank, the Brookings Institution, and USAID, where she sees opportunities for progress on global health in 2011 and...
Heart disease, high blood pressure, diabetes and cancers are usually considered diseases of the rich world, the result of too much food and too little exercise. But these serious diseases are already a huge problem in the developing world, accounting for about half of the burden of disease. Yet new...
My guest this week is Nandini Oomman, director of the Center for Global Development’s HIV/AIDS Monitor. Her team has just released a new report, Zeroing In: AIDS Donors and Africa’s Health Workforce, which looks at how AIDS programs could be better designed to strengthen the capacity of nurses...
Even as the cost of treating HIV/AIDS has fallen dramatically, the number of people newly infected has remained high. What can be done to reverse this trend and finally defeat this disease? This week on the Wonkcast, I’m joined by Mead Over, a senior fellow here at the Center for Global...
Print
Share
